De novo design of hundreds of functional GPCR-targeting antibodies enabled by scaling test-time compute
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical Report